Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3

NANot yet recruitingINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

June 30, 2028

Study Completion Date

December 31, 2028

Conditions
Staphylococcus AureusBacteremiaInfective Endocarditis
Interventions
PROCEDURE

systematic echocardiography

"transthoracic echocardiography (TTE) will be performed as soon as possible within 14 days following the first blood sample collection for SAB diagnosis, completed, if required, by a transoesophageal (TEE) echocardiography based on the judgment of the echocardiographist.~SAB in patients of both arms will be treated according to current recommendations, taking into account the result of the echocardiography in the control arm. "

PROCEDURE

no echocardiography arm

"no echocardiography will be performed unless occurrence of new events evocating IE (extra-cardiac events or positive Staphylococcus aureus blood culture), based on the clinical judgment of the investigator.~SAB in patients of both arms will be treated according to current recommendations, taking into account the result of the echocardiography in the control arm. "

Trial Locations (1)

75018

Bichat Claude Bernard Hospital, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT06457386 - Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3 | Biotech Hunter | Biotech Hunter